Abstract

Sulforaphane (SFN), a naturally-occurring isothiocyanate enriched in cabbage and broccoli, has been provided as food supplements to improve weight management and reduce lipid levels. However, its effects on serum lipid profiles are contradictory. In this review, a meta-analysis and systematic review of SFN on lipid reduction and weight control is assessed with mice and rats fed on high-fat diet. The effects of SFN supplementation were evaluated by weighted mean difference (WMD) in body weight (BW), liver weight (LW) and also by its effect on serum lipids. A random-effects model was applied to estimate the overall summary effect. SFN reduced BW (WMD: − 2.76 g, 95% CI: − 4.19, − 1.34) and LW (WMD: − 0.93 g, 95% CI: − 1.63, − 0.23) significantly in our ten trials. Its effects on serum total cholesterol (TC) (WMD: − 15.62 mg/dL, 95% CI: − 24.07, − 7.18), low-density lipoprotein cholesterol (LDL-C) (WMD: − 8.35 mg/dL, 95% CI: − 15.47, − 1.24) and triglyceride (TG) (WMD: − 40.85 mg/dL, 95% CI: − 67.46, − 14.24) were significant except for high-density lipoprotein cholesterol (HDL-C) component (WMD: 1.05 mg/dL, 95% CI: − 3.44, 5.54). However, species, disease model, duration, SFN dosage as well as route of administration did not explain the heterogeneity among studies. In summary, these findings provide new insights concerning preclinical strategies for treating diseases including obesity, diabetes, hypertension, non-alcoholic fatty liver disease as well as cardiovascular disease with SFN supplements.

Highlights

  • Sulforaphane (SFN), a naturally-occurring isothiocyanate enriched in cabbage and broccoli, has been provided as food supplements to improve weight management and reduce lipid levels

  • We considered inclusion and exclusion criteria and excluded 10 further studies owing to prescribing broccoli supplement or broccoli sprout extract instead of SFN (n = 3), acute SFN action (n = 2), randomized clinical trials (RCTs) (n = 2), rabbit model (n = 1), alcohol-induced liver steatosis model (n = 1) and lacking of clear data (n = 1) (Fig. 1)

  • We found that SFN supplementation was correlated with body weight (BW) changes (WMD: − 2.76 g, 95% CI: − 4.19, − 1.34; P = 0.032, ­I2 = 58.9%) (Fig. 2)

Read more

Summary

Introduction

Sulforaphane (SFN), a naturally-occurring isothiocyanate enriched in cabbage and broccoli, has been provided as food supplements to improve weight management and reduce lipid levels. Species, disease model, duration, SFN dosage as well as route of administration did not explain the heterogeneity among studies These findings provide new insights concerning preclinical strategies for treating diseases including obesity, diabetes, hypertension, non-alcoholic fatty liver disease as well as cardiovascular disease with SFN supplements. Sulforaphane (SFN), a natural product enriched in broccoli and cabbage, can decrease lipid levels both in vivo and in vitro[6,12,13] These studies suggest SFN may become a potential therapeutic drug for dyslipidemia. We here, provide a systematic review and meta-analysis that summarizes SFN effects on lipid profiles in animals since 2013

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call